BIOGEN INC
Reported by Old North State Wealth Management LLC
Reported 24,136 shares, down 584 (2.4%) from the prior quarter.
Reported value 2.1%; share count -2.4% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 1739420 |
| 2022-03-31 | 1714284 |
| 2022-06-30 | 2009218 |
| 2022-09-30 | 2548249 |
| 2022-12-31 | 2616245 |
| 2023-03-31 | 2703470 |
| 2023-06-30 | 2926738 |
| 2023-09-30 | 2656107 |
| 2023-12-31 | 2899430 |
| 2024-03-31 | 2659720 |
| 2024-06-30 | 3114191 |
| 2024-09-30 | 2623364 |
| 2024-12-31 | 2365313 |
| 2025-03-31 | 2723753 |
| 2025-06-30 | 2540021 |
| 2025-09-30 | 3119532 |
| 2025-12-31 | 4190266 |
| 2026-03-31 | 4509123 |
| 2026-06-30 | 5341146 |
| 2026-09-30 | 5451986 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 24,136 | -584 (-2.4%) | 2.26% | $5,451,986 | 2026-10-22 | |
| Q2 2026 | Added | 24,720 | +125 (0.5%) | 2.28% | $5,341,146 | 2026-07-17 | |
| Q1 2026 | Added | 24,595 | +786 (3.3%) | 2.09% | $4,509,123 | 2026-04-17 | |
| Q4 2025 | Added | 23,809 | +1,540 (6.9%) | 1.97% | $4,190,266 | 2026-01-23 | |
| Q3 2025 | Added | 22,269 | +2,045 (10.1%) | 1.46% | $3,119,532 | 2025-10-17 | |
| Q2 2025 | Added | 20,224 | +320 (1.6%) | 1.32% | $2,540,021 | 2025-07-16 | |
| Q1 2025 | Added | 19,904 | +4,437 (28.7%) | 1.52% | $2,723,753 | 2025-04-24 | |
| Q4 2024 | Added | 15,467 | +1,934 (14.3%) | 1.33% | $2,365,313 | 2025-01-27 | |
| Q3 2024 | Added | 13,533 | +100 (0.7%) | 1.47% | $2,623,364 | 2024-10-29 | |
| Q2 2024 | Added | 13,433 | +1,099 (8.9%) | 2.05% | $3,114,191 | 2024-10-29 | |
| Q1 2024 | Added | 12,334 | +1,130 (10.1%) | 1.74% | $2,659,720 | 2024-10-29 | |
| Q4 2023 | Added | 11,204 | +870 (8.4%) | 2.14% | $2,899,430 | 2024-10-28 | |
| Q3 2023 | Added | 10,334 | +60 (0.6%) | 2.33% | $2,656,107 | 2024-10-28 | |
| Q2 2023 | Added | 10,274 | +551 (5.7%) | 2.56% | $2,926,738 | 2024-10-28 | |
| Q1 2023 | Added | 9,723 | +276 (2.9%) | 2.53% | $2,703,470 | 2024-10-28 | |
| Q4 2022 | Reduced | 9,447 | -96 (-1.0%) | 2.63% | $2,616,245 | 2024-10-25 | |
| Q3 2022 | Reduced | 9,543 | -308 (-3.1%) | 2.94% | $2,548,249 | 2024-10-25 | |
| Q2 2022 | Added | 9,851 | +1,712 (21.0%) | 2.29% | $2,009,218 | 2024-10-25 | |
| Q1 2022 | Added | 8,139 | +890 (12.3%) | 1.71% | $1,714,284 | 2024-10-25 | |
| Q4 2021 | New | 7,249 | +7,249 (0.0%) | 1.75% | $1,739,420 | 2024-10-24 |
Who else reported the position
474 managers reported BIOGEN INC for Q3 2026 so far.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | Added | 1,158,052 | +9,484 | 0.05% | $261,588,689 | 54 qtrs |
| Pictet Asset Management Holding SA | Reduced | 832,444 | -19,375 | 0.18% | $188,229,218 | 13 qtrs |
| Citigroup Inc | Added | 746,858 | +12,341 | 0.05% | $168,700,285 | 54 qtrs |
| Robeco Institutional Asset Management B V | Reduced | 656,465 | -134,627 | 0.18% | $148,282,315 | 54 qtrs |
| Artemis Investment Management LLP | Added | 581,774 | +10,800 | 1.15% | $131,411,111 | 4 qtrs |
| Candriam S C A | Added | 412,472 | +28,146 | 0.42% | $93,509,583 | 48 qtrs |
| B Metzler seel Sohn & Co AG | Added | 403,636 | +391,378 | 0.79% | $91,173,300 | 20 qtrs |
| Sumitomo Mitsui Trust Holdings Inc | Reduced | 336,692 | -9,925 | 0.04% | $76,051,989 | 54 qtrs |
| Swedbank AB | Added | 322,494 | +1,872 | 0.06% | $72,844,943 | 23 qtrs |
| KBC Group NV | Added | 289,080 | +10,428 | 0.14% | $65,298,000 | 54 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- October 22, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 24,136
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.